Majid Ali, M.D.
August 28, 2010, The New York Times ran a front page
story entitled "Years Later, No Magic Bullet Against
Alzheimer's Disease." This was a grave disservice to
Times' readers. Consider the following quote from the
jury’s verdict was depressing and distressing. So far,
nothing has been found to prevent or delay this
devastating disease, which ceaselessly kills brain
cells, eventually leaving people mute, incontinent,
unable to feed themselves, unaware of who they are or
who their family and friends are."
So far, nothing has been
found to prevent or delay this devastating disease. This
is a shameful distortion of the facts. Alzheimer’s
disease, first and foremost, is an oxygen problem of the
brain cells caused by the trio of toxicities of foods,
environment, and thoughts, such as heavy metal overload,
toxic protein deposition, gut fermentation, and others
that block oxygen's energetic and detergent functions.
should have pointed out that this is parroting the view
of drug doctors, who do not detect nor correct nutrient
deficiencies and long-term accumulations of toxins in
the brain. This is not a potshot at the Times. Here is
my challenge to the champion of “All the News That's Fit
Give me a group of 50 patients with Alzheimer's disease,
25 in early stage of Alzheimer’s disease and 25 in the
intermediate stage of the disease. I will use my
Alzheimer's Nutrient Protocol for a period of 18 weeks
in a clinical observational study. The family members or
care providers will be asked to complete a clinical
outcome questionnaire. I predict the following rates of
positive responses in mental functions: early subgroup,
over 50%; intermediate subgroup, between 25 and 50%.
Patients with advanced with Alzheimer’s disease, in my
hands, do not respond to my Alzheimer’s Nutrient
Protocol in a clearly demonstrable way. Again, I repeat
that all relevant issues of brain toxicity-mercury, lead
and other metals, toxic protein deposition, gut
fermentation, and others that block oxygen’s energetic
and detergent functions-cannot be addressed in just
eighteen weeks. My essential point here is: It is a
blatant distortion to assert that nothing has been found
to prevent or delay this devastating disease.
Alzheimer’s Nutrient Three-Phase Study Protocol
Six-Weeks Phase I
Glutathione 400 mg
Vitamin B12 5,000 mcg
Vitamin B Complex 2 ml
Magnesium sulfate 500 mg
The above protocol will be
administered daily for three days, then on alternate
days for twelve days, and finally on every third day for
the remaining days of Phase I.
B. Intravenous Infusion
My intravenous infusion protocol includes 400 mg of
glutathione, 2,000 mg of magnesium sulfate, 500 mg of
taurine, 5,000 mcg of vitamin B12, and multivitamins. It
is administered once weekly for six weeks. For full
details concerning the composition and administration of
the infusion, I refer professional readers to Darwin,
Dysox, and Oxystatic Therapies, the 11th volume of my
textbook entitled The Principles and Practice of
Six-Weeks Phase II
All nutrient therapies will be discontinued for six
weeks and the same family members or care providers are
asked to complete the clinical outcome questionnaire.
Six-Weeks Phase III
All nutrient therapies will be reinstituted as described
in Phase I for the last six-week period. Then the same
family members or care providers are asked to complete
the clinical outcome questionnaire.
In clinical practice, of
course, I address all other oxygen issues and reduce the
dose and frequency of injectable nutrient therapies in
the long-term treatment plan.
The three-phase clinical outcome study described for
Alzheimer’s disease is based on my experience with
patients with early and intermediate stages of the
disease. Such studies are called observational studies.
The Times expressed its opinion of observational studies
with the following words:
Such studies, known as
observational ones, are not the gold standard, like
those in which people are randomly assigned to take a
pill or do something like exercise, or not.
Observational studies are useful in generating
hypotheses but are not proof. Still, if several
well-done studies of this type come to the same
conclusion, they can be valuable evidence.
If several well-done
studies of this type come to the same conclusion, they
can be valuable evidence! At least the Times recognized
Need I point out to the
Times' writer that all progress in surgical fields
was–and continues to be-made with observational studies.
The NIH Panel
Here is another quote from The New York Times concerning
the investigation by the National Institutes of Health:
Currently, "the panel
wrote, Ano evidence of even moderate scientific quality
exists to support the association of any modifiable
factor (such as nutritional supplements, herbal
preparations, dietary factors, prescription or
nonprescription drugs, social or economic factors,
medical conditions, toxins or environmental exposures)
with reduced risk of Alzheimer’s disease.
Needless to point out that
none of the members of the NIH actually practice
integrative medicine. And that is the shame of the
reports of both the National Institutes of Health and
The New York Times.
Neglected Oxygen Therapies
The common purpose in my Alzheimer’s Protocol is to
restore neuronal oxygen homeostasis, as described at
length in Oxygen and Aging (2000). This subject assumes
intense importance in light of recent reports of
compelling evidence that two types of tests, PET scans
of Alzheimer’s plaque in the brain and tests of spinal
fluid, can predict the development of disease with near
certainty years before the disease is clinically
Please consider our DVD on
Only $15 Free shipping